Pexacerfont

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NamePexacerfont
Drug Alias Name培沙舍封pexacerfontum培萨舍芳BMS-562086
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticotropin-releasing factor receptor 1 antagonists
TargetsCorticotropin-releasing factor receptor 1
Therapy Area/IndicationsDepressive Disorder, MajorAnxiety DisordersAlcoholism +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute On Alcohol Abuse And Alcoholism
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol Myers Squibb SrlcompanyNational Institute On Alcohol Abuse And Alcoholism
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorAnxiety DisordersAlcoholism +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG